|
OTP-01 Clinical Trials
1 actively recruiting trial across 1 location
Grand Rapids, Michigan1 trial
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
South Texas Accelerated Research Therapeutics (START) Midwest
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.